The trading price of iBio Inc (AMEX:IBIO) closed higher on Thursday, March 29, closing at $4.06, 20.83% higher than its previous close.
In examining the 52-week price action we see that the stock hit a 52-week high of $49.80 and a 52-week low of $1.02. Over the past month, the stock has gained 235.54% in value.
iBio Inc, whose market valuation is $14.13 million at the time of this writing, is expected to release its quarterly earnings report May 13, 2024 – May 17, 2024. Investors’ optimism about the company’s current quarter earnings report is understandable. Analysts have predicted the quarterly earnings per share to grow by $0 per share this quarter, however they have predicted annual earnings per share of $0 for 2024 and $0 for 2025.
From the analysts’ viewpoint, the consensus estimate for the company’s annual revenue in 2024 is $800k.
A company’s earnings reviews provide a brief indication of a stock’s direction in the short term, where in the case of iBio Inc No upward and no downward comments were posted in the last 7 days. On the technical side, indicators suggest IBIO has a Hold on average for the short term. According to the data of the stock’s medium term indicators, the stock is currently averaging as a 50% Sell, while an average of long term indicators suggests that the stock is currently Hold.
A quick review shows that IBIO’s price is currently 222.54% off the SMA20 and 239.54% off the SMA50. The RSI metric on the 14-day chart is currently showing 95.45, and weekly volatility stands at 24.27%. When measured over the past 30 days, the indicator reaches 9.55%. iBio Inc (AMEX:IBIO)’s beta value is currently sitting at -3.61, while the Average True Range indicator is currently displaying 0.35.
To see how iBio Inc stock has been performing in comparison to its peers in the industry, here are the numbers: IBIO stock’s performance was 20.83% in the latest trading, and -91.29% in the past year.
An evaluation of the daily trading volume of iBio Inc (AMEX:IBIO) indicates that the 3-month average is 2.85 million. However, this figure has increased over the past 10 days to an average of 22.2 million.
Currently, records show that 3.48 million of the company’s shares remain outstanding. The insiders hold 0.39% of outstanding shares, whereas institutions hold 7.22%. The stats also highlight that short interest as of Mar 15, 2024, stood at 59320.0 shares, resulting in a short ratio of 0.43 at that time. From this, we can conclude that short interest is 1.70% of the company’s total outstanding shares. It is noteworthy that short shares in March were up slightly from the previous month’s figure, which was 13990.0. However, since the stock’s price has seen 196.35% year-to-date, investors’ interest is likely to be reignited due to its potential to move even higher.
